Gene: DNAAF5
Official Full Name: dynein axonemal assembly factor 5provided by HGNC
Gene Summary: The protein encoded by this gene is essential for the preassembly or stability of axonemal dynein arms, and is found only in organisms with motile cilia and flagella. Mutations in this gene are associated with primary ciliary dyskinesia-18, a disorder characterized by abnormalities of motile cilia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18252 | DNAAF5 Knockout cell line (HeLa) | Human | DNAAF5 | 1:3~1:6 | Negative | Online Inquiry |
KO18253 | DNAAF5 Knockout cell line (HCT 116) | Human | DNAAF5 | 1:2~1:4 | Negative | Online Inquiry |
KO18254 | DNAAF5 Knockout cell line (HEK293) | Human | DNAAF5 | 1:3~1:6 | Negative | Online Inquiry |
KO18255 | DNAAF5 Knockout cell line (A549) | Human | DNAAF5 | 1:3~1:4 | Negative | Online Inquiry |
DNAAF5 Gene Knockout Cell Lines are specialized cellular models in which the DNAAF5 gene, known for its role in ciliary function and respiratory health, has been intentionally disrupted. This process is achieved through advanced gene-editing techniques such as CRISPR-Cas9, enabling researchers to create knockout cell lines that exhibit specific phenotypic changes associated with the absence of DNAAF5. By studying these cell lines, scientists can gain invaluable insights into the gene's function, its contributions to ciliary motility, and the underlying mechanisms of diseases such as primary ciliary dyskinesia.
The primary function of DNAAF5 is linked to the assembly and stability of the dynein motor complex, essential for the proper movement of cilia. In the absence of DNAAF5, researchers can observe alterations in cellular behavior and ciliary structure, thus facilitating a detailed understanding of ciliary dysfunctions. The cells derived from DNAAF5 knockout models are pivotal for experimental setups aimed at exploring genetic disorders, understanding the molecular pathways involved in ciliary-related diseases, and testing therapeutic interventions.
The scientific importance of DNAAF5 Gene Knockout Cell Lines extends beyond basic research; they serve as critical tools in preclinical studies for drug development and efficacy testing, especially in the context of respiratory diseases. Compared to conventional cell lines, these knockout models offer a more precise platform for elucidating gene function and therapeutic potency, ensuring that research outcomes are grounded in true genetic manipulation rather than approximations.
One of the key advantages of choosing our DNAAF5 knockout cell lines is their rigorously validated genetic modification and consistent performance across experimental applications. This reliability significantly reduces variability and enhances reproducibility in research findings. Furthermore, these cell lines are optimized for easy handling and integration into various assays, saving time and resources in the lab.
For researchers and clinicians striving to unravel the complexities of ciliary diseases or seeking new therapeutic strategies, DNAAF5 Gene Knockout Cell Lines represent an essential component of their research arsenal. Our commitment to providing high-quality biological products underscores our company's expertise in genetic tools and cell line development, ensuring our customers have access to cutting-edge resources that support their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.